← Companies|Paratek Pharma
PR

Paratek Pharma

PRTK·NASDAQBoston MAFounded 2006100 employees
Micro CapbiotechPublicInfectious Disease
Platform: Nuzyra Antibio
Market Cap
$0.05B
All Drugs
2
Clinical Trials
3
Failed / Terminated
1
FDA Approved
0
Stock Price & Catalysts (PRTK)
Loading PRTK stock data...
Drug Pipeline (2 programs)
Drug NameCodePhaseTrialsModalityTargetMOAIndications
TixacilimabPRT-7162Phase 1/22Small MoleculeFcRnMeniniACCCRC
PRT-4395PRT-4395Phase 21Gene TherapyGPRC5DWRNiHeart FailureGBM
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (3)
2025-03-10
Tixacilimab Ph2 Data
CRC
Past
2025-11-12
Tixacilimab Ph2 Data
CRC
Past
2027-10-07
PRT-4395 Ph2 Data
GBM
Ph2 Data